François Villeret

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2024
Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-making.

François Villeret, Pierre Nahon

|Nov 27, 2023
Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients.

Domitille Erard, François Villeret, Yasmina Chouik

|Oct 25, 2023
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.

Barbara Testoni, Caroline Scholtès, Marie-Laure Plissonnier

|Dec 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?

Gael S Roth, François Villeret, Thomas Decaens

|Sep 21, 2022
Response to 'Predictors of mid-term survival after liver transplantation in patients with NAFLD cirrhosis'.

François Villeret, Jérôme Dumortier

|Aug 04, 2022
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.

François Villeret, Sébastien Dharancy, Domitille Erard

Pageof 1

Frequent Collaborators

3 joint publications

Jérôme Dumortier

2 joint publications

Pierre Nahon

1 joint publications

Louise Barbier

1 joint publications

Olivier Boillot